Across TCGA pan-cancer cohorts, NUP62CL RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated NUP62CL data layer compared with 2 for mutation status.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher NUP62CL RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NUP62CL expression acts as an unfavorable survival marker, although some lineages such as CESC and KIRC show a favorable association.
LUAD, LGG, and THCA are the cancer types where NUP62CL RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.